论文信息 - Germline and somatic mutations in prostate cancer: focus on defective DNA repair, PARP inhibitors and immunotherapy. - 字舞流文

Germline and somatic mutations in prostate cancer: focus on defective DNA repair, PARP inhibitors and immunotherapy.

A. Lopez‐Beltran | R. Montironi | Liang Cheng | M. Scarpelli | A. Cimadamore | F. Massari | M. Santoni | R. Mazzucchelli | A. Galosi | A. López-Beltran